Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. [electronic resource]
Producer: 20080513Description: 1499-509 p. digitalISSN:- 1537-6591
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Aza Compounds -- administration & dosage
- Bacteria -- isolation & purification
- Ceftriaxone -- administration & dosage
- Community-Acquired Infections -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Fluoroquinolones
- Humans
- Levofloxacin
- Male
- Middle Aged
- Moxifloxacin
- Ofloxacin -- administration & dosage
- Pneumonia, Bacterial -- drug therapy
- Prospective Studies
- Quinolines -- administration & dosage
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.